[{"Assets_0_Q3_USD":44625100000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":4075800000.0,"NetIncomeLoss_1_Q3_USD":1149500000.0,"NetIncomeLoss_3_Q3_USD":2107000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1026300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1037800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1020400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1033200000.0,"StockholdersEquity_0_Q3_USD":13076600000.0,"EarningsPerShareBasic_1_Q3_USD":1.13,"EarningsPerShareBasic_3_Q3_USD":2.04,"EarningsPerShareDiluted_1_Q3_USD":1.12,"EarningsPerShareDiluted_3_Q3_USD":2.03,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20181106"}]